{
    "nctId": "NCT02299063",
    "officialTitle": "The Protective Effect of the \u03b12-agonist Dexmedetomidine on Mitochondrial Structure and Function for Children With Non-cyanotic Congenital Heart Defects Having Cardiac Surgery: A Randomized Controlled Trial.",
    "inclusionCriteria": "* aged between 3 - 36 months\n* having primary corrective heart surgery\n* Must have minimum age of 3 Months\n* Must have maximum age of 36 Months",
    "exclusionCriteria": "* recent surgery (\\< 3 months)\n* previous chemotherapy\n* previous transfusion of blood products\n* neurodevelopmental disorders (including Trisomy 21)\n* supplemental oxygen requirement (\\< 3 months)\n* asthma requiring regular therapy\n* obstructive sleep apnea\n* the presence of concurrent infection or inflammation\n* a known allergy to dexmedetomidine hydrochloride"
}